(Q35220653)

7 August 2017

Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience (English)

1 reference

7 August 2017

25

Herve Avet-Loiseau

0 references

Cyrille Hulin

6

Cyrille Hulin

0 references

Xavier Leleu

7

Xavier Leleu

0 references

Florence Magrangeas

2

Florence Magrangeas

0 references

Thierry Facon

19

Thierry Facon

1 reference

7 August 2017

20

Philippe Moreau

1 reference

7 August 2017

Valérie Lauwers-Cancès

4

Valerie Lauwers-Cances

1 reference

7 August 2017

21

Michel Attal

1 reference

7 August 2017

9

Gerald Marit

1 reference

7 August 2017

22

Nikhil Munshi

1 reference

7 August 2017

24

Stephane Minvielle

1 reference

7 August 2017

1

Benjamin Hebraud

1 reference

7 August 2017

3

Alice Cleynen

1 reference

7 August 2017

Marie-Lorraine Chretien

5

Marie-Lorraine Chretien

1 reference

7 August 2017

8

Edwige Yon

1 reference

7 August 2017

10

Lionel Karlin

1 reference

7 August 2017

11

Murielle Roussel

1 reference

7 August 2017

12

Anne-Marie Stoppa

1 reference

7 August 2017

13

Karim Belhadj

1 reference

7 August 2017

14

Laurent Voillat

1 reference

7 August 2017

15

Laurent Garderet

1 reference

7 August 2017

18

Mohamad Mohty

1 reference

7 August 2017

23

Jill Corre

1 reference

7 August 2017

16

Margaret Macro

1 reference

7 August 2017

Denis Caillot

17

1 reference

7 August 2017

language of work or name

English

0 references

publication date

30 January 2015

1 reference

7 August 2017

1 reference

7 August 2017

125

1 reference

7 August 2017

2095-2100

1 reference

7 August 2017

13

1 reference

Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

Prognostic significance of copy-number alterations in multiple myeloma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

Clinical and biologic implications of recurrent genomic aberrations in myeloma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375107

In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression

15 November 2018

1 reference

12 December 2020

The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis

1 reference

12 December 2020

Cytogenetic findings in 200 patients with multiple myeloma

1 reference

12 December 2020

Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations

1 reference

12 December 2020

Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated

1 reference

12 December 2020

Hypodiploidy is a major prognostic factor in multiple myeloma

1 reference

12 December 2020

10.1182/BLOOD-2014-07-587964

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference